
Louise Wang Zhiying Humphrey
Examiner (ID: 17515)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1657, 1648 |
| Total Applications | 628 |
| Issued Applications | 269 |
| Pending Applications | 52 |
| Abandoned Applications | 313 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5793467
[patent_doc_number] => 20060014148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Igg fc/hiv-gp120/c3d fusion protien'
[patent_app_type] => utility
[patent_app_number] => 10/518523
[patent_app_country] => US
[patent_app_date] => 2003-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3267
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014148.pdf
[firstpage_image] =>[orig_patent_app_number] => 10518523
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/518523 | Igg fc/hiv-gp120/c3d fusion protien | Jul 22, 2003 | Abandoned |
Array
(
[id] => 7291803
[patent_doc_number] => 20040110922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Chimeric proteins for prevention and treatment of hiv infection'
[patent_app_type] => new
[patent_app_number] => 10/466836
[patent_app_country] => US
[patent_app_date] => 2003-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12258
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110922.pdf
[firstpage_image] =>[orig_patent_app_number] => 10466836
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/466836 | Chimeric proteins for prevention and treatment of hiv infection | Jul 21, 2003 | Abandoned |
Array
(
[id] => 7473963
[patent_doc_number] => 20040097409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes'
[patent_app_type] => new
[patent_app_number] => 10/624947
[patent_app_country] => US
[patent_app_date] => 2003-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 33113
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20040097409.pdf
[firstpage_image] =>[orig_patent_app_number] => 10624947
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/624947 | Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes | Jul 20, 2003 | Abandoned |
Array
(
[id] => 7122401
[patent_doc_number] => 20050014230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Preparation of fully human antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/622003
[patent_app_country] => US
[patent_app_date] => 2003-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9714
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20050014230.pdf
[firstpage_image] =>[orig_patent_app_number] => 10622003
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/622003 | Preparation of fully human antibodies | Jul 15, 2003 | Abandoned |
Array
(
[id] => 7395194
[patent_doc_number] => 20040018177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-29
[patent_title] => 'Vacination method'
[patent_app_type] => new
[patent_app_number] => 10/345000
[patent_app_country] => US
[patent_app_date] => 2003-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12231
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20040018177.pdf
[firstpage_image] =>[orig_patent_app_number] => 10345000
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/345000 | Vacination method | Jul 14, 2003 | Abandoned |
Array
(
[id] => 7369335
[patent_doc_number] => 20040092723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Compositions and methods for the intracellular delivery of antibodies'
[patent_app_type] => new
[patent_app_number] => 10/618179
[patent_app_country] => US
[patent_app_date] => 2003-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5722
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20040092723.pdf
[firstpage_image] =>[orig_patent_app_number] => 10618179
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/618179 | Compositions and methods for the intracellular delivery of antibodies | Jul 10, 2003 | Abandoned |
Array
(
[id] => 7347518
[patent_doc_number] => 20040248084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/612603
[patent_app_country] => US
[patent_app_date] => 2003-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 28855
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248084.pdf
[firstpage_image] =>[orig_patent_app_number] => 10612603
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/612603 | Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors | Jun 30, 2003 | Issued |
Array
(
[id] => 7177687
[patent_doc_number] => 20050123899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Anti-hiv agent'
[patent_app_type] => utility
[patent_app_number] => 10/500774
[patent_app_country] => US
[patent_app_date] => 2003-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7528
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123899.pdf
[firstpage_image] =>[orig_patent_app_number] => 10500774
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/500774 | Anti-hiv agent | Jun 29, 2003 | Abandoned |
Array
(
[id] => 373221
[patent_doc_number] => 07473524
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-06
[patent_title] => 'Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance'
[patent_app_type] => utility
[patent_app_number] => 10/518525
[patent_app_country] => US
[patent_app_date] => 2003-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5305
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/473/07473524.pdf
[firstpage_image] =>[orig_patent_app_number] => 10518525
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/518525 | Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance | Jun 29, 2003 | Issued |
Array
(
[id] => 484963
[patent_doc_number] => 07217506
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-15
[patent_title] => 'Mutational profiles in HIV-1 protease correlated with phenotypic protease inhibitor resistance'
[patent_app_type] => utility
[patent_app_number] => 10/519035
[patent_app_country] => US
[patent_app_date] => 2003-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6636
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/217/07217506.pdf
[firstpage_image] =>[orig_patent_app_number] => 10519035
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/519035 | Mutational profiles in HIV-1 protease correlated with phenotypic protease inhibitor resistance | Jun 29, 2003 | Issued |
Array
(
[id] => 7463836
[patent_doc_number] => 20040101534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Adjuvant-free peptide vaccine'
[patent_app_type] => new
[patent_app_number] => 10/603094
[patent_app_country] => US
[patent_app_date] => 2003-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9855
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20040101534.pdf
[firstpage_image] =>[orig_patent_app_number] => 10603094
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/603094 | Adjuvant-free peptide vaccine | Jun 24, 2003 | Abandoned |
Array
(
[id] => 5590895
[patent_doc_number] => 20060040347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Use of triplex structure DNA in transferring nucleotide sequences'
[patent_app_type] => utility
[patent_app_number] => 10/602663
[patent_app_country] => US
[patent_app_date] => 2003-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 13896
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20060040347.pdf
[firstpage_image] =>[orig_patent_app_number] => 10602663
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/602663 | Use of triplex structure DNA in transferring nucleotide sequences | Jun 24, 2003 | Abandoned |
Array
(
[id] => 5914084
[patent_doc_number] => 20060128941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Pokeweed antiviral protein polypeptides with antiviral activity'
[patent_app_type] => utility
[patent_app_number] => 10/518142
[patent_app_country] => US
[patent_app_date] => 2003-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18861
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20060128941.pdf
[firstpage_image] =>[orig_patent_app_number] => 10518142
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/518142 | Pokeweed antiviral protein polypeptides with antiviral activity | Jun 16, 2003 | Abandoned |
Array
(
[id] => 7306912
[patent_doc_number] => 20040116684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Ancestral viruses and vaccines'
[patent_app_type] => new
[patent_app_number] => 10/441949
[patent_app_country] => US
[patent_app_date] => 2003-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 29544
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20040116684.pdf
[firstpage_image] =>[orig_patent_app_number] => 10441949
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/441949 | Ancestral viruses and vaccines | May 18, 2003 | Abandoned |
Array
(
[id] => 7304012
[patent_doc_number] => 20040115621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Ancestral viruses and vaccines'
[patent_app_type] => new
[patent_app_number] => 10/441926
[patent_app_country] => US
[patent_app_date] => 2003-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 25317
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20040115621.pdf
[firstpage_image] =>[orig_patent_app_number] => 10441926
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/441926 | Ancestral viruses and vaccines | May 18, 2003 | Abandoned |
Array
(
[id] => 7020369
[patent_doc_number] => 20050222388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Fusion protein of hiv regulatory/accessory proteins'
[patent_app_type] => utility
[patent_app_number] => 10/514740
[patent_app_country] => US
[patent_app_date] => 2003-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7595
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222388.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514740
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514740 | Fusion protein of hiv regulatory/accessory proteins | May 13, 2003 | Abandoned |
Array
(
[id] => 5880537
[patent_doc_number] => 20060029619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter'
[patent_app_type] => utility
[patent_app_number] => 10/514922
[patent_app_country] => US
[patent_app_date] => 2003-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6147
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20060029619.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514922
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514922 | Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter | May 13, 2003 | Abandoned |
Array
(
[id] => 7069045
[patent_doc_number] => 20050244428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)'
[patent_app_type] => utility
[patent_app_number] => 10/514761
[patent_app_country] => US
[patent_app_date] => 2003-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 10589
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20050244428.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514761
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514761 | Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) | May 13, 2003 | Issued |
Array
(
[id] => 7469954
[patent_doc_number] => 20040121316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Method and compositions for identifying anti-HIV therapeutic compounds'
[patent_app_type] => new
[patent_app_number] => 10/424186
[patent_app_country] => US
[patent_app_date] => 2003-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 195882
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20040121316.pdf
[firstpage_image] =>[orig_patent_app_number] => 10424186
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/424186 | Method and compositions for identifying anti-HIV therapeutic compounds | Apr 24, 2003 | Abandoned |
Array
(
[id] => 5613887
[patent_doc_number] => 20060115815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Method and compositions for identifying anti-hiv therapeutic compounds'
[patent_app_type] => utility
[patent_app_number] => 10/511183
[patent_app_country] => US
[patent_app_date] => 2003-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 195758
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20060115815.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511183
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511183 | Method and compositions for identifying anti-hiv therapeutic compounds | Apr 24, 2003 | Abandoned |